Methyl 5-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate, 97%, 1g

methyl 2-[(4-nitro-1H-pyrazol-1-yl)methyl]benzoate, 100g

2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetic acid, 95.0%, 25g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

3-(Pyridin-3-yl)benzaldehyde, 95.0%, 5g

(Z)-Ethyl 2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetate, 97%, 25g

4-Bromo-6-hydroxyisoindolin-1-one, 95.0%, 250mg

2-Dimethylamino-pyrimidine-5-carbaldehyde, 95.0%, 10g

[(3-isobutyl-5-isoxazolyl)methyl]amine hydrochloride, 95.0%, 1g

3-Methoxy-3-methyl-1-butanol, min. 99%, for synthesis, 100 ml, glass packaging

Triphenylen-2-ylboronic acid, 95.0%, 5g

tert-Butyl N-[3-(aminomethyl)benzyl]carbamate, 97.0%, 10g

Pyridazine-4-carbonitrile, 95.0%, 5g